ArticleSpringerPlus2016

Telbivudine for the treatment of chronic hepatitis B in HBeAg-positive patients in China: a health economic analysis.

S Banerjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.